We are live on ! Find out more

29 hedge funds and large institutions have $26M invested in IRIDEX in 2021 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

175% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 4

151% more capital invested

Capital invested by funds: $10.4M → $26M (+$15.7M)

32% more funds holding

Funds holding: 2229 (+7)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

4.85% less ownership

Funds ownership: 29.68%24.84% (-4.8%)

33% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 9

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $78K

Holders
29
Holders Change
+7
Holders Change %
+31.82%
% of All Funds
0.51%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
11
Increased
6
Reduced
9
Closed
4
Calls
Puts
$78K
Net Calls
-$78K
Net Calls Change
-$78K

IRIX Hedge Fund Activity: Q1 2021 in Review

29 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in IRIDEX (IRIX) for Q1 2021, worth a combined $26M — up 151% from $10.4M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new IRIX positions and 4 closed out — a net gain of 7 holders — while 6 added to existing stakes and 9 trimmed.

The largest buyer was EAM Investors, opening a new position worth an estimated $1.06M. The largest seller was Invenomic Capital Management, cutting an estimated $1.97M.

  • 29 institutional investors held IRIDEX (IRIX) as of Q1 2021, up from 22 in Q4 2020.
  • Funds reported $26M of IRIDEX stock for Q1 2021, up 151% quarter-over-quarter.
  • 11 funds opened new IRIDEX positions in Q1 2021 and 4 closed out, a net change of +7 holders.
  • The largest IRIDEX buyer in Q1 2021 was EAM Investors, an estimated $1.06M added.
  • The largest IRIDEX seller in Q1 2021 was Invenomic Capital Management, an estimated $1.97M sold.

Based on aggregated 13F filings for Q1 2021.